LIFR and idiopathic pulmonary fibrosis: Interestingly, a recent report investigating novel therapeutic targets in idiopathic pulmonary fibrosis (IPF) identified Leukemia Inhibitory Factor receptor (LIFR) as an “autocrine master amplifier” of multiple upstream activators of lung fibroblasts (32).